![Dalriada Therapeutics logo](https://facit.ca/wp-content/uploads/2021/11/Dalriada.png)
Dalriada Therapeutics
www.dalriadatx.com
Innovation Type:
Therapeutics
Cancer Type:
Heme
Funding Stage:
Seed
Fund:
Prospects
Developing a DT-1 class of small molecules, for the treatment of leukemia, with selective cancer cell-killing activity and reduced toxicity due to a unique cloaking mechanism.